Your browser doesn't support javascript.
loading
Impact of the COVID-19 Pandemic on Diabetic Foot Patients: A Shift in the Infectious Agent Profile Toward Nonfermentative Gram-Negative Bacilli.
Acar, Ali; Saltoglu, Nese; Tülek, Necla; Turhan, Özge; Serin, Elif Nazli; Yapar, Derya; Kendirci, Murat; Sürme, Serkan; Karaca, Banu Yildiz; Altay, Fatma Aybala; Taysi, Ridvan; Sencan, Irfan; Tanyel, Esra; Bilek, Heval Can; Güler, Özlem; Mutlu, Birsen; Aksan, Tolga; Karadag, Fatma Yilmaz; Kadanali, Ayten; Altunal, Lütfiye Nilsun; Oglu, Moumperra Chral; Senbayrak, Seniha; Erol, Serpil; Ak, Öznur; Aladag, Nazire; Demirtürk, Nese; Konya, Petek; Bulut, Dilek; Engin, Derya Öztürk; Aslan, Hasan Murat; Kaya, Sibel Dogan.
  • Acar A; 1Department of Medical Microbiology, Atilim University School of Medicine, Ankara, Turkey.
  • Saltoglu N; 2Bayindir Healthcare Group, Infectious Diseases Clinic, Sogutozu Hospital, Ankara, Turkey.
  • Tülek N; 3Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Turhan Ö; 1Department of Medical Microbiology, Atilim University School of Medicine, Ankara, Turkey.
  • Serin EN; 4Department of Infectious Diseases and Clinical Microbiology, Akdeniz University School of.
  • Yapar D; 5Department of Endocrinology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Kendirci M; 6Department of Infectious Diseases and Clinical Microbiology, Hitit University School of Medicine,Ulukavak, Çorum, Turkey.
  • Sürme S; 7Department of General Surgery, Hitit University School of Medicine,Ulukavak, Çorum, Turkey.
  • Karaca BY; 3Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Altay FA; 8Department of Infectious Diseases and Clinical Microbiology, Izmir Katip Çelebi University Faculty of Medicine, Çigli, Izmir, Turkey.
  • Taysi R; 9Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, Turkey.
  • Sencan I; 9Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, Turkey.
  • Tanyel E; 9Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, Turkey.
  • Bilek HC; 10Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Faculty of Medicine, Atakum, Samsun, Turkey.
  • Güler Ö; 10Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Faculty of Medicine, Atakum, Samsun, Turkey.
  • Mutlu B; 11Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Kocaeli University, Izmit, Kocaeli, Turkey.
  • Aksan T; 11Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Kocaeli University, Izmit, Kocaeli, Turkey.
  • Karadag FY; 12Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Kadiköy, Istanbul, Turkey.
  • Kadanali A; 12Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Kadiköy, Istanbul, Turkey.
  • Altunal LN; 13Department of Infectious Diseases and Clinical Microbiology, Biruni University, Medical School, Zeytinburnu, Istanbul, Turkey.
  • Oglu MC; 14Department of Infectious Diseases and Clinical Microbiology, Istanbul Umraniye Training and Research Hospital, Ümraniye, Istanbul, Turkey.
  • Senbayrak S; 14Department of Infectious Diseases and Clinical Microbiology, Istanbul Umraniye Training and Research Hospital, Ümraniye, Istanbul, Turkey.
  • Erol S; 13Department of Infectious Diseases and Clinical Microbiology, Biruni University, Medical School, Zeytinburnu, Istanbul, Turkey.
  • Ak Ö; 15Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Aladag N; 15Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Demirtürk N; 16Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kütahya Health Sciences University, Zafertepe, Kütahya, Turkey.
  • Konya P; 17Department of Internal Medicine, Health Sciences University, Kartal Dr. Lütfi Kirdar Training and Research Hospital, Kartal, Istanbul, Turkey.
  • Bulut D; 18Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Afyon Saglik Bilimleri University, Afyon, Turkey.
  • Engin DÖ; 18Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Afyon Saglik Bilimleri University, Afyon, Turkey.
  • Aslan HM; 19Department of Infectious Diseases and Clinical Microbiology, Van Training and Research Hospital, Edremit, Van, Turkey.
  • Kaya SD; 20Department of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey.
Article en En | MEDLINE | ID: mdl-39058633
ABSTRACT

BACKGROUND:

Diabetes foot infection is a very important public health problem that causes serious health problems, mortality, and high health expenditures, and is one of the most important complications of diabetes mellitus. There are concerns that approaches such as limited personal visits to doctors, avoidance of hospitals, and restrictions on nonemergency surgical procedures during the coronavirus disease of 2019 pandemic pose a threat to those with diabetic foot problems, including diabetic foot ulcers (DFUs), ischemia, and infection, resulting in increased limb loss and mortality.

METHODS:

This multicenter, retrospective, cross-sectional study was conducted in 14 tertiary care hospitals from various regions of Turkey. A total of 1,394 patient records were evaluated, 794 of which were between January 1, 2019, and January 30, 2020 (prepandemic [Pre-P]), and 605 of which were between February 1, 2020, and February 28, 2021 (pandemic period [PP]).

RESULTS:

During the PP, diabetic foot patient follow-up decreased by 23.8%. In addition, the number of hospitalizations attributable to DFU has decreased significantly during the PP (P = .035). There was no difference between the groups regarding patient demographics, medical history, DFU severity, biochemical and radiologic findings, or comorbidities, but the mean duration of diabetes mellitus years was longer in patients in the Pre-P than in those in the PP (15.1 years versus 13.7 years). There was no difference between the two groups in terms of major complications such as limb loss and mortality, but infection recurrence was higher in the PP than in the Pre-P (12.9% versus 11.4%; P < .05). The prevalence of nonfermentative gram-negative bacteria as causative agents in DFU infections increased during the PP. In particular, the prevalence of carbapenem-resistant Pseudomonas spp. increased statistically during the PP.

CONCLUSIONS:

The rapid adaptation to the pandemic with the measures and changes developed by the multidisciplinary diabetic foot care committees may be the reasons why there was no increase in complications because of DFU during the pandemic in Turkey.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pie Diabético / COVID-19 Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pie Diabético / COVID-19 Límite: Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article